ASVRX
Price
$9.15
Change
-$0.53 (-5.48%)
Updated
Feb 3 closing price
Net Assets
3.93B
AXVIX
Price
$19.94
Change
+$1.21 (+6.46%)
Updated
Feb 3 closing price
Net Assets
30.96M
Interact to see
Advertisement

ASVRX vs AXVIX

Header iconASVRX vs AXVIX Comparison
Open Charts ASVRX vs AXVIXBanner chart's image
American Century Small Cap Value R
Price$9.15
Change-$0.53 (-5.48%)
VolumeN/A
Net Assets3.93B
Acclivity Small Cap Value I
Price$19.94
Change+$1.21 (+6.46%)
VolumeN/A
Net Assets30.96M
ASVRX vs AXVIX Comparison Chart in %
View a ticker or compare two or three
VS
ASVRX vs. AXVIX commentary
Feb 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ASVRX is a Buy and AXVIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
ASVRX has more cash in the bank: 3.93B vs. AXVIX (31M). AXVIX pays higher dividends than ASVRX: AXVIX (1.66) vs ASVRX (0.57). ASVRX was incepted earlier than AXVIX: ASVRX (16 years) vs AXVIX (7 years). ASVRX (1.58) is less costly to investors than AXVIX (1.04). AXVIX is a more actively managed with annual turnover of: 96.00 vs. ASVRX (39.00). ASVRX has a lower initial minimum investment than AXVIX: ASVRX (2500) vs AXVIX (20000). AXVIX annual gain was more profitable for investors over the last year : 8.95 vs. ASVRX (-10.37). AXVIX return over 5 years is better than : 53.34 vs. ASVRX (0.82).
ASVRXAXVIXASVRX / AXVIX
Total Expense Ratio1.580.48329%
Annual Report Gross Expense Ratio1.581.04152%
Fund Existence16 years7 years-
Gain YTD6.6437.26291%
Front LoadN/AN/A-
Min. Initial Investment25002000013%
Min. Initial Investment IRAN/AN/A-
Net Assets3.93B31M12,668%
Annual Yield % from dividends0.571.6635%
Returns for 1 year-10.378.95-116%
Returns for 3 years-7.1719.46-37%
Returns for 5 years0.8253.342%
Returns for 10 years42.38N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GEV780.2525.28
+3.35%
GE Vernova
ANAB51.210.67
+1.33%
AnaptysBio
JMSB20.990.06
+0.29%
John Marshall Bancorp
ATRA5.04N/A
N/A
Atara Biotherapeutics Inc.
DOCS34.85-2.44
-6.54%
Doximity